Stockholm Stock Exchange | Mid Cap
Xvivo Perfusion
3 months
SEBDNBPareto SecuritiesDanske Bank MarketsDNB MarketsSEB EquitiesCarnegieBryan GarnierDanske Bank

Price Targets For Xvivo Perfusion

AnalystPrice TargetDateUpside
SEB500 SEKMay 29
DNB468 SEKApr 26
Pareto Securities420 SEKApr 25
Danske Bank Markets405 SEKApr 15
DNB Markets418 SEKJan 29
SEB Equities390 SEKJan 26
Carnegie350 SEKJan 26
Bryan Garnier340 SEKNov -23
Danske Bank403 SEKOct -22

About The Company

XVIVO is a medical technology company firmly rooted within medical science with more than 20 years of experience in the transplantation area.
Xvivo Perfusion